BioNTech SE (22UA.F) Stock Price
€95.8 0.3%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
6 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on BioNTech SE, AI stock picks, stock alerts and much more.
22UA.F AI Stock Analysis
AI stock analysis for 22UA.F is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like BioNTech SE (22UA.F) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
BioNTech SE (22UA.F) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of BioNTech SE (22UA.F), currently trading at €95.8, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 22UA.F
-
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases.
-
Symbol
22UA.F
-
Market
XETRA
-
Industry
Biotechnology
-
Market Cap
23B
Similar Stocks
 |
CureVac 5CV.F |
€4.64 1% |
5 |
 |
Novavax NVV1.F |
€6.74 1.8% |
3 |
 |
Heidelberg Pharma AG HPHA.DE |
€4.38 1.4% |
7 |
 |
Formycon AG FYB.DE |
€24.5 1.5% |
6 |
 |
BRAIN Biotech AG BNN.DE |
€2.09 3% |
4 |
News
22UA.F Alternative Data
Web Traffic
BioNTech SE receives an estimated 57143 monthly visitors to biontech.de.
-
Web Traffic
57143
-
Change from Previous Month
3.1%
-
3 Month Change
9.7%
-
YoY Change
9.7%
Twitter Followers
BioNTech SE has 80,870 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
80870
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Youtube Subscribers
BioNTech SE has 504 subscribers on its main Youtube channel, up by 0.8% over the last month.
-
Youtube Subscribers
504
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
3.3%
Job Postings
BioNTech SE currenly has an estimated 122 open job postings, up by 2.5% over the last month.
-
Job Postings
122
-
Daily Change
1.6%
-
1 Month Change
2.5%
-
3 Month Change
10.9%
-
YoY Change
10.9%
Reddit Mentions
BioNTech SE has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
273,517 are following BioNTech SE on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
273517
-
Daily Change
0.9%
-
1 Month Change
0.9%
-
3 Month Change
3.7%
-
YoY Change
3.7%
LinkedIn Employees
According to LinkedIn, BioNTech SE has 5,035 employees, down by -0.7% over the last month.
-
LinkedIn Employees
5035
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Business Outlook
According to employee reviews, the business outlook among employees at BioNTech SE is 35 out of 100 (bearish).
-
Business Outlook
35
-
Change from Previous Month
0%
-
3 Month Change
2.9%
-
YoY Change
2.9%
News Mentions
BioNTech SE was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
22UA.F Financials
22UA.F Key Metrics
-
Total Revenue
€182.8M
-
Net Income
-€415.8M
-
Earnings per Share
-€1.73
-
Free cash flow
-€1.4B
-
EBITDA
-€368.7M
-
EBITDA Ratio
-2.01696
-
Total Assets
€21.2B
22UA.F 2-year Revenue & Income
22UA.F 2-year Free Cash Flow
22UA.F Technicals
22UA.F SMA
22UA.F RSI
FAQ
What's the current price of BioNTech SE (22UA.F) Stock?
The price of an BioNTech SE (22UA.F) share is €95.8.
What's the market cap of BioNTech SE?
The current market cap of BioNTech SE is 23B.
Should I buy or sell 22UA.F?
BioNTech SE shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, BioNTech SE is better viewed as a hold or accumulate position while waiting for further developments.
Is BioNTech SE a good investment?
The current analysis of BioNTech SE's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in BioNTech SE's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy BioNTech SE (22UA.F) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for BioNTech SE stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to BioNTech SE (22UA.F) that investors often compare it to?
BioNTech SE (22UA.F) is often compared to similar stocks such as CureVac, Novavax, Heidelberg Pharma AG, Formycon AG and BRAIN Biotech AG.
What is the forecast for BioNTech SE's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast BioNTech SE's stock price to be around €94.88 in 2026. Starting from the current price of €95.8, this represents a 1% change in price, indicating a neutral outlook for the stock.
How to buy BioNTech SE (22UA.F) Stock?
BioNTech SE stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy BioNTech SE shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.